AstraZeneca's (AZN) Imfinzi plus Lynparza for treating certain patients with primary advanced or recurrent endometrial cancer is approved in the EU...

A recent study published in JAMA Network Open has revealed that maintaining stable blood sugar levels within personalized target ranges may help...

A key driver in Brain Health growth is Quest Diagnostics' (DGX) Alzheimer's disease portfolio, featuring the AD-Detect blood testing services and the...

People 60 and older with untreated high blood pressure may have an increased risk of Alzheimer's disease compared to both people who have been or are...

New targets and biomarkers linked to Alzheimer's disease, proven in a study at Emory University, paving the way for potential innovative therapies.

Cognitive decline can vary widely, from mild memory lapses to severe dementia, which can significantly disrupt daily life. Alzheimer’s disease is...

THURSDAY, Aug. 15, 2024 -- Untreated high blood pressure in your 60s could raise your risk for Alzheimer's disease later, new research shows. The good...

Researchers at Cedars-Sinai conducted a thorough study to understand how changes in the retina relate to brain changes in Alzheimer’s disease. This...

A groundbreaking study has mapped the genetic blueprints of 47 Lyme disease bacteria strains from across the globe, promising a new era in...

Alzheimer’s disease is a progressive brain disorder that leads to memory loss, confusion, and difficulty with thinking and reasoning. It’s the...